Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
067370
vs
K
KOSPI 200
Over the past 12 months, Sun Bio Inc has underperformed KOSPI 200, delivering a return of +5% compared to KOSPI 200's +56% growth.
Stocks Performance
067370 vs KOSPI 200
Performance Gap
067370 vs KOSPI 200
Performance By Year
067370 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sun Bio Inc
Glance View
SunBio, Inc. develops biosimilars, biopharmaceuticals, medical devices, and cosmetic products based on proprietary technologies comprised of site-directed pegylation of proteins, cell engineering technology, and novel pegylation technologies. The company is headquartered in Incheon, Incheon. The company went IPO on 2016-01-22. The firm is mainly engaged in the production and sale of Polyethylene Glycol (PEG) derivative material business, development, production and sale of neutropenia treatments and dry mouth treatments. In addition, the Company is engaged in research, development, production and sales of bio-new drugs and medical devices. The firm sells its products in domestic and overseas markets.